Degradation of Cdc25A by β-TrCP during S phase and in response to DNA damage
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
The Cdc25A phosphatase is essential for cell-cycle progression because of its function in dephosphorylating cyclin-dependent kinases. In response to DNA damage or stalled replication, the ATM and ATR protein kinases activate the checkpoint kinases Chk1 and Chk2, which leads to hyperphosphorylation of Cdc25A. These events stimulate the ubiquitin-mediated proteolysis of Cdc25A and contribute to delaying cell-cycle progression, thereby preventing genomic instability. Here we report that beta-TrCP is the F-box protein that targets phosphorylated Cdc25A for degradation by the Skp1/Cul1/F-box protein complex. Downregulation of beta-TrCP1 and beta-TrCP2 expression by short interfering RNAs causes an accumulation of Cdc25A in cells progressing through S phase and prevents the degradation of Cdc25A induced by ionizing radiation, indicating that beta-TrCP may function in the intra-S-phase checkpoint. Consistent with this hypothesis, suppression of beta-TrCP expression results in radioresistant DNA synthesis in response to DNA damage--a phenotype indicative of a defect in the intra-S-phase checkpoint that is associated with an inability to regulate Cdc25A properly. Our results show that beta-TrCP has a crucial role in mediating the response to DNA damage through Cdc25A degradation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The intermediate component of this pathway is β-TrcP (an adaptor protein) that links both WEE1 [346] and claspin [347–349] with the SCF ubiquitin ligase complex and this SCFβTrcP acts as trigger of checkpoint initiation where recognition of phosphodegron β-TrcP is exposed after Chk1 mediated Phosphorylation of Cdc25A [350], as well as checkpoint recovery which is linked with Plk1 mediated Phospho”
From Molecular Mechanisms of Ultraviolet Radiation‐Induced DNA Damage and Repair (2010) · cites this paper as [350]
Citations
Cites
Control of β-Catenin Phosphorylation/Degradation by a Dual-Kinase Mechanism
Liu, C., Li, Y., Semenov, M., Han, C., Baeg, G.-H., Tan, Y., Zhang, Z., Lin, X., & He, X. (2002) · Cell · doi:10.1016/s0092-8674(02)00685-2 · Cited by 2,069
SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27
Carrano, A. C., Eytan, E., Hershko, A., & Pagano, M. (1999) · Nature Cell Biology · doi:10.1038/12013 · Cited by 1,543 · cited 1×
“In vitro ubiquitination assay Ubiquitin ligation was determined essentially as describe”
Self-citationThe ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis
Falck, J., Mailand, N., Syljuåsen, R. G., Bartek, J., & Lukas, J. (2001) · Nature · doi:10.1038/35071124 · Cited by 1,085
Winston, J. T., Strack, P., Beer-Romero, P., Chu, C. Y., Elledge, S. J., & Harper, J. W. (1999) · Genes & Development · doi:10.1101/gad.13.3.270 · Cited by 954
Heterozygous Germ Line hCHK2 Mutations in Li-Fraumeni Syndrome
Bell, D. W., Varley, J. M., Szydlo, T. E., Kang, D. H., Wahrer, D. C. R., Shannon, K. E., Lubratovich, M., Verselis, S. J., Isselbacher, K. J., Fraumeni, J. F., et al. (1999) · Science · doi:10.1126/science.286.5449.2528 · Cited by 904
Radiosensitivity in ataxia-telangiectasia: a new explanation.
Painter, R. B., & Young, B. R. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.12.7315 · Cited by 789 · cited 1×
“Radioresistant DNA synthesis (RDS), a phenotype indicative of a defective intra-S-phase checkpoint, occurs in cells deficient for ATM and Chk2, two upstream negative effectors of Cdc25A abundanc”
Rapid Destruction of Human Cdc25A in Response to DNA Damage
Mailand, N., Falck, J., Lukas, C., Syljuåsen, R. G., Welcker, M., Bartek, J., & Lukas, J. (2000) · Science · doi:10.1126/science.288.5470.1425 · Cited by 787
Multisite phosphorylation of a CDK inhibitor sets a threshold for the onset of DNA replication
Nash, P., Tang, X., Orlicky, S., Chen, Q., Gertler, F. B., Mendenhall, M. D., Sicheri, F., Pawson, T., & Tyers, M. (2001) · Nature · doi:10.1038/35107009 · Cited by 759 · cited 1×
“23 ), multiple phosphorylation events on the target protein enhance its interaction with the F-box protein and stimulate its polyubiquitinatio”
Kipreos, E. T., & Pagano, M. (2000) · Genome biology · doi:10.1186/gb-2000-1-5-reviews3002 · Cited by 753 · cited 1×
“To achieve this, we screened several human F-box protein”
Self-citationIdentification of the receptor component of the IκBα–ubiquitin ligase
Yaron, A., Hatzubai, A., Davis, M., Lavon, I., Amit, S., Manning, A. M., Andersen, J. S., Mann, M., Mercurio, F., & Ben-Neriah, Y. (1998) · Nature · doi:10.1038/25159 · Cited by 654
Cited by
NF‐κB and the link between inflammation and cancer
DiDonato, J. A., Mercurio, F., & Karin, M. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01099.x · Cited by 1,482
Ubiquitin ligases: cell-cycle control and cancer
Nakayama, K. I., & Nakayama, K. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1881 · Cited by 1,433
Molecular Mechanisms of Ultraviolet Radiation‐Induced DNA Damage and Repair
Rastogi, R. P., Richa, Kumar, A., Tyagi, M. B., & Sinha, R. P. (2010) · Journal of Nucleic Acids · doi:10.4061/2010/592980 · Cited by 1,329
Regulation of DNA repair throughout the cell cycle
Branzei, D., & Foiani, M. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2351 · Cited by 1,228
The SCF ubiquitin ligase: insights into a molecular machine
Cardozo, T., & Pagano, M. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1471 · Cited by 1,114
“SCF β-Trcp has recently been shown to degrade phosphorylated Cdc25a in the S and G2 phase”
BackgroundSelf-citationDeregulated proteolysis by the F-box proteins SKP2 and β-TrCP: tipping the scales of cancer
Frescas, D., & Pagano, M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2396 · Cited by 890
“gov/cancertopics/types/melanoma/">melanoma and breast cancer cells, and augments the cytotoxic effects of anticancer drugs and ionizing radiatio”
BackgroundSelf-citationPost-translational modifications in signal integration
Deribe, Y. L., Pawson, T., & Dikic, I. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1842 · Cited by 876
“Phosphorylation of Cdc25C by checkpoint kinases leads to its sequestration and inactivation by 14-3-3 proteins, whereas the phosphorylation of Cdc25A leads to creation of the classic DSGXXS degradation motif (degron), its ubiquitination by the ligase SCF βTrCP and its degradation, which inhibits the Cdk1 (refs”
BackgroundDNA damage checkpoints: from initiation to recovery or adaptation
Bartek, J., & Lukas, J. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.02.009 · Cited by 784
Muscle-specific microRNA miR-206 promotes muscle differentiation
Kim, H. K., Lee, Y. S., Sivaprasad, U., Malhotra, A., & Dutta, A. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200603008 · Cited by 766
“DNA synthesis was measured as described previously (Busino et al., 2003) with minor modifi cations.”
Checking on DNA damage in S phase
Bartek, J., Lukas, C., & Lukas, J. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1493 · Cited by 758
CDC25 phosphatases in cancer cells: key players? Good targets?
Boutros, R., Lobjois, V., & Ducommun, B. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2169 · Cited by 714
“SCF βTRCP -dependent degradation of CDC25A in S-phase requires phosphorylation of serine clusters by CHK1 and/or CHK2 and another as yet unknown kinas”
BackgroundPan, Y., Bai, C. B., Joyner, A. L., & Wang, B. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.9.3365-3377.2006 · Cited by 518
Patsoukis, N., Brown, J., Petkova, V., Liu, F., Li, L., & Boussiotis, V. A. (2012) · Science Signaling · doi:10.1126/scisignal.2002796 · Cited by 529
Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2
Reinhardt, H. C., & Yaffe, M. B. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.01.018 · Cited by 497
Ubiquitin ligases in oncogenic transformation and cancer therapy
Senft, D., Qi, J., & Ronai, Z. A. (2018) · Nature Reviews Cancer · doi:10.1038/nrc.2017.105 · Cited by 489
A hitchhiker's guide to the cullin ubiquitin ligases: SCF and its kin
Willems, A. R., Schwab, M., & Tyers, M. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2004.09.027 · Cited by 464
M-phase kinases induce phospho-dependent ubiquitination of somatic Wee1 by SCF β-TrCP
Watanabe, N., Arai, H., Nishihara, Y., Taniguchi, M., Watanabe, N., Hunter, T., & Osada, H. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307700101 · Cited by 472
Ubiquitylation in apoptosis: a post-translational modification at the edge of life and death
Vucic, D., Dixit, V. M., & Wertz, I. E. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3143 · Cited by 444
“However, inhibition of both βTRCP isoforms by RNA interference (RNAi), or expression of dominant-negative mutants, promotes apoptosis, probably owing to an accumulation of pro-apoptotic substrate”
BackgroundTong, K. I., Padmanabhan, B., Kobayashi, A., Shang, C., Hirotsu, Y., Yokoyama, S., & Yamamoto, M. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00753-07 · Cited by 442
The when and wheres of CDC25 phosphatases
Boutros, R., Dozier, C., & Ducommun, B. (2006) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2006.02.003 · Cited by 414
The Cdc14B-Cdh1-Plk1 Axis Controls the G2 DNA-Damage-Response Checkpoint
Bassermann, F., Frescas, D., Guardavaccaro, D., Busino, L., Peschiaroli, A., & Pagano, M. (2008) · Cell · doi:10.1016/j.cell.2008.05.043 · Cited by 397
“The latter is known to be degraded via SCFbTrcp after genotoxic stresses (Busino et al., 2003; Jin et al., 2003), and, in fact, its levels did not increase when Cdh1 was silenced (Figure 2A).”
BackgroundInfluentialSelf-citationMammalian cell cycle checkpoints: signalling pathways and their organization in space and time
Lukas, J., Lukas, C., & Bartek, J. (2004) · DNA Repair · doi:10.1016/j.dnarep.2004.03.006 · Cited by 381
Regulation of the cell cycle by SCF-type ubiquitin ligases
NAKAYAMA, K., & NAKAYAMA, K. (2005) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2005.02.010 · Cited by 360
Ubiquitin signaling in cell cycle control and tumorigenesis
Dang, F., Nie, L., & Wei, W. (2021) · Cell Death & Differentiation · doi:10.1038/s41418-020-00648-0 · Cited by 348
A Role for the Deubiquitinating Enzyme USP28 in Control of the DNA-Damage Response
Zhang, D., Zaugg, K., Mak, T. W., & Elledge, S. J. (2006) · Cell · doi:10.1016/j.cell.2006.06.039 · Cited by 326
Regulation of NF‐κB by ubiquitination and degradation of the IκBs
Kanarek, N., & Ben‐Neriah, Y. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01098.x · Cited by 324
APC/C and SCF: Controlling Each Other and the Cell Cycle
Vodermaier, H. C. (2004) · Current Biology · doi:10.1016/j.cub.2004.09.020 · Cited by 318
“In this case, kinases phosphorylate Cdc25A to create a β-TrCP phosphodegron (consisting of the sequence DSGxxS, where both serines have to be phosphorylated), thus making the phosphatase a target for ubiquitination by SCF1βTrCP [90,91].”
BackgroundBuisson, R., Boisvert, J. L., Benes, C. H., & Zou, L. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.07.029 · Cited by 316
“Furthermore, CDC25A, which is degraded in a Chk1-dependent manner (Busino et al., 2003; A E RPA14 RPA70 0h 16 h 18 h 20 h 22 h 16 h 18 h 20 h 22 h DMSO ATRi Serum starvation (2 days) Release +/-ATRi (16 to 22 h) Cyclin A RPA32 GAPDH γH2AX RRM2 Em pt y v ec to r HA -RR M2 ATRi HA 0h 0h4h 8h 4h…”
SCFβ-TRCP controls oncogenic transformation and neural differentiation through REST degradation
Westbrook, T. F., Hu, G., Ang, X. L., Mulligan, P., Pavlova, N. N., Liang, A., Leng, Y., Maehr, R., Shi, Y., Harper, J. W., et al. (2008) · Nature · doi:10.1038/nature06780 · Cited by 311
The combined status of ATM and p53 link tumor development with therapeutic response
Jiang, H., Reinhardt, H. C., Bartkova, J., Tommiska, J., Blomqvist, C., Nevanlinna, H., Bartek, J., Yaffe, M. B., & Hemann, M. T. (2009) · Genes & Development · doi:10.1101/gad.1815309 · Cited by 304
“Our observation of a synthetic lethal interaction between p53 and ATM/Chk2 in the context of DNAdamaging chemotherapy likely also applies to the other two DNA damage effector kinase pathways that establish similar cell cycle checkpoints through inhibiting the Cdc25 family of phosphatases ( Busino et al. 2003; Reinhard…”
BackgroundFu, X., Richards, D. E., Fleck, B., Xie, D., Burton, N., & Harberd, N. P. (2004) · The Plant Cell · doi:10.1105/tpc.021386 · Cited by 295
“the specific domain of the target protein with which the F-box protein interacts that are targeted for phosphorylation (e.g., Busino et al., 2003 ).”
BackgroundInfluentialShirogane, T., Jin, J., Ang, X. L., & Harper, J. W. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502862200 · Cited by 293
ATR: a master conductor of cellular responses to DNA replication stress
Flynn, R. L., & Zou, L. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.09.005 · Cited by 290
Peschiaroli, A., Dorrello, N. V., Guardavaccaro, D., Venere, M., Halazonetis, T., Sherman, N. E., & Pagano, M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.06.013 · Cited by 289
“During S phase, bTrCP directs the degradation of Cdc25A, preventing premature hyperactivation of Cdk1 and entry into mitosis prior to the completion of DNA synthesis ( Busino et al., 2003; Jin et al., 2003).”
BackgroundInfluentialSelf-citationBassermann, F., Eichner, R., & Pagano, M. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.02.028 · Cited by 268
Self-citationEvidence for the direct involvement of βTrCP in Gli3 protein processing
Wang, B., & Li, Y. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509927103 · Cited by 273
Phospho-Ser/Thr-binding domains: navigating the cell cycle and DNA damage response
Reinhardt, H. C., & Yaffe, M. B. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3640 · Cited by 266
14-3-3 proteins as signaling integration points for cell cycle control and apoptosis
Gardino, A. K., & Yaffe, M. B. (2011) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2011.09.008 · Cited by 263
“Cdc25A has been generally accepted as being primarily regulated in response to DNA damage by Chk1-dependent phosphorylation and β-TrCP-mediated ubiquitination and proteosomal degradation [85–87].”
BackgroundUbiquitin Ligases and Cell Cycle Control
Teixeira, L. K., & Reed, S. I. (2013) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060410-105307 · Cited by 252
Stracker, T. H., Usui, T., & Petrini, J. H. J. (2009) · DNA Repair · doi:10.1016/j.dnarep.2009.04.012 · Cited by 243
“The effector kinases negatively regulate the Cdc25s through phosphorylation that controls their binding to 14-3-3 proteins, nucelo-cytoplasmic shuttling, and binding of the SCFβTrcp ubiquitin ligase that targets Cdc25A for degradation by the proteasome to activate the intra-S phase checkpoint [52–55].”
BackgroundMailand, N., Bekker-Jensen, S., Bartek, J., & Lukas, J. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.06.016 · Cited by 258
The SCF/Slimb Ubiquitin Ligase Limits Centrosome Amplification through Degradation of SAK/PLK4
Cunha-Ferreira, I., Rodrigues-Martins, A., Bento, I., Riparbelli, M., Zhang, W., Laue, E., Callaini, G., Glover, D. M., & Bettencourt-Dias, M. (2009) · Current Biology · doi:10.1016/j.cub.2008.11.037 · Cited by 255
Ahn, J., Urist, M., & Prives, C. (2004) · DNA Repair · doi:10.1016/j.dnarep.2004.03.033 · Cited by 240
14-3-3 Proteins—a focus on cancer and human disease
Wilker, E., & Yaffe, M. B. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.04.015 · Cited by 252
The Multifaceted Roles of USP7: New Therapeutic Opportunities
Nicholson, B., & Suresh Kumar, K. G. (2011) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-011-9185-5 · Cited by 240
Tempé, D., Casas, M., Karaz, S., Blanchet-Tournier, M.-F., & Concordet, J.-P. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.02183-05 · Cited by 249
The Role of Cdc25A in the Regulation of Cell Proliferation and Apoptosis
Shen, T., & Huang, S. (2012) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152012800617678 · Cited by 225
The ubiquitous role of ubiquitin in the DNA damage response
Al-Hakim, A., Escribano-Diaz, C., Landry, M.-C., O’Donnell, L., Panier, S., Szilard, R. K., & Durocher, D. (2010) · DNA Repair · doi:10.1016/j.dnarep.2010.09.011 · Cited by 223
“CHK1/CHK2-dependent phosphorylation of CDC25A facilitates its recognition by SCF TrCP [156, 157] .”
Cdc25A phosphatase: combinatorial phosphorylation, ubiquitylation and proteolysis
Busino, L., Chiesa, M., Draetta, G. F., & Donzelli, M. (2004) · Oncogene · doi:10.1038/sj.onc.1207394 · Cited by 211
“Cluster I serines are absolutely required for efficient binding to the SCFbTrCP, while none of cluster II phosphorylation sites are involved in binding these SCF components (Busino et al., 2003).”
BackgroundSelf-citationSarkar, S., Dey, B. K., & Dutta, A. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-01-0062 · Cited by 204
“Although Cdc25A undergoes degradation by proteasome pathways upon DNA damage (Busino et al., 2003; Jin et al., 2003; Kanemori et al., 2005), such degradation has not been implicated in a differentiation pathway.”
Abbas, T., Keaton, M. A., & Dutta, A. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a012914 · Cited by 195
“10 Cite this article as Cold Spring Harb Perspect Biol 2013;5:a012914 Cdc25A on multiple serine residues resulting in its proteolytic degradation via the SCFbetaTRCP pathway (Falck et al. 2001; Zhao et al. 2002; Busino et al. 2003; Hassepass et al. 2003).”
The roles of E3 ubiquitin ligases in cancer progression and targeted therapy
Sampson, C., Wang, Q., Otkur, W., Zhao, H., Lu, Y., Liu, X., & Piao, H. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1204 · Cited by 182
TAZ Promotes PC2 Degradation through a SCFβ-Trcp E3 Ligase Complex
Tian, Y., Kolb, R., Hong, J.-H., Carroll, J., Li, D., You, J., Bronson, R., Yaffe, M. B., Zhou, J., & Benjamin, T. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00254-07 · Cited by 187
“The cyclin-cdk inhibitor p27 (8, 61) as a known target of Cul1 and cdc25A as a known target of Cul1 and -Trcp ( 5 , 28) were used as positive controls.”
MethodSCF-mediated protein degradation and cell cycle control
Ang, X. L., & Wade Harper, J. (2005) · Oncogene · doi:10.1038/sj.onc.1208614 · Cited by 193
“In response to DNA damage, Cdc25A is targeted for destruction by a pathway that depends upon the Chk1 kinase and bTRCP (Busino et al., 2003; Jin et al., 2003).”
BackgroundClaspin Operates Downstream of TopBP1 To Direct ATR Signaling towards Chk1 Activation
Liu, S., Bekker-Jensen, S., Mailand, N., Lukas, C., Bartek, J., & Lukas, J. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00492-06 · Cited by 182
Control of chromosome stability by the β-TrCP–REST–Mad2 axis
Guardavaccaro, D., Frescas, D., Dorrello, N. V., Peschiaroli, A., Multani, A. S., Cardozo, T., Lasorella, A., Iavarone, A., Chang, S., Hernando, E., et al. (2008) · Nature · doi:10.1038/nature06641 · Cited by 188
Self-citationCoupling of Homologous Recombination and the Checkpoint by ATR
Buisson, R., Niraj, J., Rodrigue, A., Ho, C. K., Kreuzer, J., Foo, T. K., Hardy, E. J.-L., Dellaire, G., Haas, W., Xia, B., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2016.12.007 · Cited by 181
“Through Chk1-mediated degradation or inhibition of CDC25 phospha- tases (Busino et al., 2003; Jin et al., 2003; Mailand et al., 2000; Peng et al., 1997; Sanchez et al., 1997), the ATR-Chk1 pathway suppresses activities of CDK2 and CDK1, thereby hindering origin firing and mitotic entry.”
BackgroundFunctions, Regulation, and Therapeutic Implications of the ATR Checkpoint Pathway
Yazinski, S. A., & Zou, L. (2016) · Annual Review of Genetics · doi:10.1146/annurev-genet-121415-121658 · Cited by 175
Ferguson, A. M., White, L. S., Donovan, P. J., & Piwnica-Worms, H. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.7.2853-2860.2005 · Cited by 164
Lebeau, A., Bruyère, D., Roncarati, P., Peixoto, P., Hervouet, É., Cobraiville, G., Taminiau, B., Masson, M., Gallego, C., Mazzucchelli, G., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28724-8 · Cited by 176
Kang, T., Wei, Y., Honaker, Y., Yamaguchi, H., Appella, E., Hung, M.-C., & Piwnica-Worms, H. (2008) · Cancer Cell · doi:10.1016/j.ccr.2007.12.002 · Cited by 164
“…for subsequent phosphorylation of S82, which is critical for b-TrCP binding, and that Chk1 also phosphorylates S76 (Bartek and Lukas, 2003; Busino et al., 2003; Donzelli et al., 2004; Goloudina et al., 2003; Hassepass et al., 2003; Jin et al., 2003; Ray et al., 2005; Sorensen et al.,…”
BackgroundInfluentialFbxw7α- and GSK3-mediated degradation of p100 is a pro-survival mechanism in multiple myeloma
Busino, L., Millman, S. E., Scotto, L., Kyratsous, C. A., Basrur, V., O’Connor, O., Hoffmann, A., Elenitoba-Johnson, K. S., & Pagano, M. (2012) · Nature Cell Biology · doi:10.1038/ncb2463 · Cited by 167
Self-citationProteomic analyses reveal distinct chromatin‐associated and soluble transcription factor complexes
Li, X., Wang, W., Wang, J., Malovannaya, A., Xi, Y., Li, W., Guerra, R., Hawke, D. H., Qin, J., & Chen, J. (2015) · Molecular Systems Biology · doi:10.15252/msb.20145504 · Cited by 181
“Indeed, we identified many known bTRCP2interacting proteins, which include CUL1, SKP1 (Lyapina et al, 1998; Wu et al, 2000), USP37 (Burrows et al, 2012), USP47 (Peschiaroli et al, 2010), EEF2K (Meloche & Roux, 2012), CDC25A (Busino et al, 2003) and CTNNB1 (Hart et al, 1999) (Fig 5D).”
Control of cell growth by the SCF and APC/C ubiquitin ligases
Skaar, J. R., & Pagano, M. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.08.004 · Cited by 181
Self-citationTargeting the ubiquitin pathway for cancer treatment
Liu, J., Shaik, S., Dai, X., Wu, Q., Zhou, X., Wang, Z. P., & Wei, W. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.11.005 · Cited by 155
Kumar, S., Krolewski, J. J., & Fuchs, S. Y. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407082200 · Cited by 150
Phosphorylation of p53 by IκB kinase 2 promotes its degradation by β-TrCP
Xia, Y., Padre, R. C., de Mendoza, T. H., Bottero, V., Tergaonkar, V., & Verma, I. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812256106 · Cited by 149
Circadian gene variants in cancer
Kettner, N. M., Katchy, C. A., & Fu, L. (2014) · Annals of Medicine · doi:10.3109/07853890.2014.914808 · Cited by 147
Mészáros, B., Kumar, M., Gibson, T. J., Uyar, B., & Dosztányi, Z. (2017) · Science Signaling · doi:10.1126/scisignal.aak9982 · Cited by 157
PD-1 inhibits T cell proliferation by upregulating p27 and p15 and suppressing Cdc25A
Patsoukis, N., Sari, D., & Boussiotis, V. A. (2012) · Cell Cycle · doi:10.4161/cc.22135 · Cited by 143
Cdc7 Inhibition Reveals a p53-Dependent Replication Checkpoint That Is Defective in Cancer Cells
Montagnoli, A., Tenca, P., Sola, F., Carpani, D., Brotherton, D. H., Albanese, C., & Santocanale, C. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1547 · Cited by 154
Targeting DNA repair pathway in cancer: Mechanisms and clinical application
Wang, M., Chen, S., & Ao, D. (2021) · MedComm · doi:10.1002/mco2.103 · Cited by 150
Insights into APC/C: from cellular function to diseases and therapeutics
Zhou, Z., He, M., Shah, A. A., & Wan, Y. (2016) · Cell Division · doi:10.1186/s13008-016-0021-6 · Cited by 154
Ubiquitination and Degradation of the Inhibitors of NF- BPreprint
Kanarek, N., London, N., Schueler‐Furman, O., & Ben‐Neriah, Y. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000166 · Cited by 137
“…cell fate (the IkBs), development and tissue organization (b-catenin, Snail), many cell cycle regulators (Emi1, Wee1), and DNA damage responders (Claspin, Cdc25A) (Jiang and Struhl 1998; Busino et al. 2003; Guardavaccaro et al. 2003; Watanabe et al. 2004; Zhou et al. 2004; Peschiaroli et al. 2006).”
BackgroundChk1, but not Chk2, inhibits Cdc25 phosphatases by a novel common mechanism.
Uto, K., Inoue, D., Shimuta, K., Nakajo, N., & Sagata, N. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600328 · Cited by 134
“…sites and target it rapidly for ubiquitin-dependent degradation (Mailand et al, 2000, 2002; Molinari et al, 2000; Falck et al, 2001; Shimuta et al, 2002; Busino et al, 2003), which is thought to be central to the S and G2 cell cycle checkpoints (Bartek and Lukas, 2003; Donzelli and Draetta, 2003).”
BackgroundNEK11 regulates CDC25A degradation and the IR-induced G2/M checkpoint
Melixetian, M. B., Klein, D. K., Sørensen, C. S., & Helin, K. (2009) · Nature Cell Biology · doi:10.1038/ncb1969 · Cited by 149
“According to the proposed model, CHK1 initially phosphorylates Ser 76, which primes CDC25A for subsequent phosphorylation on Ser 79, 82 and 88 (Ref”
The utility F-box for protein destruction
Ho, M. S.-C., Ou, C.-Y., Chan, Y., Chien, C., & Pi, H. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7592-6 · Cited by 131
SPRINT: an SNP-free toolkit for identifying RNA editing sites
Zhang, F., Lu, Y., Yan, S., Xing, Q., & Tian, W. (2017) · Bioinformatics · doi:10.1093/bioinformatics/btx473 · Cited by 148
“These genes include Btrc that functioned in cell cycle checkpoints (Busino et al. , 2003; Jin et al. , 2003), and Mad2l2 that is required by pluripotent embryonic stem cells (Pirouz et al. , 2015), etc.”
BackgroundKanemori, Y., Uto, K., & Sagata, N. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501873102 · Cited by 128
How protein kinases co-ordinate mitosis in animal cells
Ma, H. T., & Poon, R. Y. C. (2011) · Biochemical Journal · doi:10.1042/bj20100284 · Cited by 145
Karimian, A., Majidinia, M., Baghi, H. B., & Yousefi, B. (2017) · DNA repair · doi:10.1016/j.dnarep.2017.01.003 · Cited by 125
Oocytes Progress beyond Prophase in the Presence of DNA Damage
Marangos, P., & Carroll, J. (2012) · Current Biology · doi:10.1016/j.cub.2012.03.063 · Cited by 127
“Cell-cycle arrest at the G2 stage is a result of a Chk1/Chk2-dependent degradation of the Cdc25A phosphatase [8–10], but in some cases the inhibitory phosphorylation of Cdc25B or Cdc25C [11, 12], leading to a failure to activate cyclin B-CDK1 [9–11].”
Yan, Q., Zeng, Z., Gong, Z., Zhang, W., Li, X., He, B., Song, Y., Li, Q., Zeng, Y., Liao, Q., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6155 · Cited by 121
Clijsters, L., Hoencamp, C., Calis, J. J. A., Marzio, A., Handgraaf, S. M., Cuitiño, M. C., Rosenberg, B. R., Leone, G. W., & Pagano, M. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.04.010 · Cited by 127
“—F-box proteins were STREP-STREP-tagged and cloned into a modified pcDNA3 (Clontech), as previously described (Busino et al., 2003).”
MethodSelf-citationPal, S., Bhattacharjee, A., Ali, A., Mandal, N. C., Mandal, S. C., & Pal, M. (2014) · Journal of Inflammation · doi:10.1186/1476-9255-11-23 · Cited by 124
“These players include program cell death regulator (PDC4) [201], myeloid cell leukemia 1 (Mcl-1) [202] and cell cycle division cycle homologue 25A (CDC25A) [203,204].”
BackgroundThe multiple checkpoint functions of CHK1 and CHK2 in maintenance of genome stability.
Chen, Y., & Poon, R. Y. C. (2008) · PubMed · doi:10.2741/3060 · Cited by 143
Gastaldello, S., Hildebrand, S., Faridani, O. R., Callegari, S., Palmkvist, M., Guglielmo, C. D., & Masucci, M. G. (2010) · Nature Cell Biology · doi:10.1038/ncb2035 · Cited by 116
Targeting the Checkpoint to Kill Cancer Cells
Benada, J., & Macůrek, L. (2015) · Biomolecules · doi:10.3390/biom5031912 · Cited by 124
“Cdc25A phosphorylated at Ser-76 is subsequently ubiquitinated by SCF/ TrCP ubiquitin ligase complex and degraded by proteasome [90–92].”
BackgroundThe Fbw7 and BetaTRCP E3 ubiquitin ligases and their roles in tumorigenesis
Alan, W. L. (2012) · Frontiers in bioscience · doi:10.2741/4045 · Cited by 114
USP7 counteracts SCFβTrCP- but not APCCdh1-mediated proteolysis of Claspin
Faustrup, H., Bekker-Jensen, S., Bartek, J., Lukas, J., & Mailand, N. (2009) · The Journal of Cell Biology · doi:10.1083/jcb.200807137 · Cited by 113
“DNA damage triggers rapid degradation of the Cdk-activating phosphatase , Cdc25A, by the SCF  TrCP ubiquitin ligase to arrest the cell cycle in a reversible fashion ( Mailand et al., 2000 ; Busino et al., 2003 ).”
BackgroundEichelbaum, K., & Krijgsveld, J. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.030916 · Cited by 121
Tekcham, D. S., Chen, D., Liu, Y., Ling, T., Zhang, Y., Chen, H., Wang, W., Otkur, W., Qi, H., Xia, T., et al. (2020) · Theranostics · doi:10.7150/thno.42735 · Cited by 111
DUAL SPECIFICITY PROTEIN PHOSPHATASES: Therapeutic Targets for Cancer and Alzheimer's Disease
Ducruet, A. P., Vogt, A., Wipf, P., & Lazo, J. S. (2004) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.100040 · Cited by 110
Directing the use of DDR kinase inhibitors in cancer treatment
Brandsma, I., Fleuren, E. D. G., Williamson, C. T., & Lord, C. J. (2017) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2017.1389895 · Cited by 119
Ubiquitin–proteasome system and the role of its inhibitors in cancer therapy
Aliabadi, F., Sohrabi, B., Mostafavi, E., Pazoki–Toroudi, H., & Webster, T. J. (2021) · Open Biology · doi:10.1098/rsob.200390 · Cited by 111
“It also inhibits the action of Cdk1 by destroying CDC25A (M-phase inducer phosphatase 1) in cooperation with the Chk1 in response to genotoxic stress [125,126] and results in blocking of cell cycle development before DNA repair is completed.”
Background14‐3‐3γ mediates Cdc25A proteolysis to block premature mitotic entry after DNA damage
Kasahara, K., Goto, H., Enomoto, M., Tomono, Y., Kiyono, T., & Inagaki, M. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.157 · Cited by 105
“For example, Chk1 induces Cdc25A-Ser76 phosphorylation, which results in bTrCP-dependent Cdc25A degradation (Busino et al, 2003, 2004; Jin et al, 2003; Neely and Piwnica-Worms, 2003; Melixetian et al, 2009).”
BackgroundThe Role of Checkpoint Kinase 1 in Sensitivity to Topoisomerase I Poisons
Flatten, K. S., Dai, N. T., Vroman, B. T., Loegering, D. A., Erlichman, C., Karnitz, L. M., & Kaufmann, S. H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411890200 · Cited by 104
Smad4 Protein Stability Is Regulated by Ubiquitin Ligase SCFβ-TrCP1
Wan, M., Tang, Y., Tytler, E. M., Lu, C., Jin, B., Vickers, S. M., Yang, L. F., Shi, X., & Cao, X. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400005200 · Cited by 103
Liu, P., Barkley, L. R., Day, T. A., Bi, X., Slater, D., Alexandrow, M. G., Nasheuer, H., & Vaziri, C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602982200 · Cited by 102
The Emerging Role of the COP9 Signalosome in Cancer
Richardson, K. S., & Zundel, W. (2005) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0233 · Cited by 101
Metadata
- Authors
- Busino, L., Donzelli, M., Chiesa, M., Guardavaccaro, D., Ganoth, D., Valerio Dorrello, N., Hershko, A., Pagano, M., & Draetta, G. F.
- Affiliations
- European Institute of Oncology (IT)
- New York University (US)
- Technion – Israel Institute of Technology (IL)
- Corresponding author
- Donzelli, Maddalena
- Venue
- Nature
- Published
- 2003-11
- Volume
- 426
- Issue
- 6962
- Pages
- 87-91
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1969210627
- Cited by
- 447
- References
- 28
- Citations by year
- 2026: 8 · 2025: 13 · 2024: 6 · 2023: 13 · 2022: 10 · 2021: 15 · 2020: 21 · 2019: 13 · 2018: 17 · 2017: 23 · 2016: 21 · 2015: 23 · 2014: 18 · 2013: 20 · 2012: 32
- FWCI
- 8.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- Cdc25A phosphatase, β-TrCP, F-box protein, ubiquitin-mediated proteolysis, S-phase checkpoint, DNA damage response, ionizing radiation, radioresistant DNA synthesis, ATM kinase, ATR kinase, Chk1, Chk2, cell cycle progression, genomic instability
- MeSH terms
- Amino Acid Sequence, Binding Sites, DNA Damage, HeLa Cells, Humans, Molecular Sequence Data, Phosphorylation, Protein Binding, Radiation, Ionizing, S Phase, cdc25 Phosphatases, Amino Acid Motifs, Ubiquitin, beta-Transducin Repeat-Containing Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.